Testing effectiveness (Phase 2)UnknownNCT02520453What this trial is testingAdjuvant Durvalumab for Esophageal CancerWho this might be right forEsophageal Cancer Samsung Medical Center 86
Not applicableUnknownNCT05615103What this trial is testingThe PET-CT Predicting Response to Immunochemotherapy in Esophageal CancerWho this might be right forEsophageal Cancer Guangdong Provincial People's Hospital 100
Testing effectiveness (Phase 2)WithdrawnNCT02034968What this trial is testingNimotuzumab Plus Nab-paclitaxel and Cisplatin in Treating Patients With Advanced Esophageal CarcinomaWho this might be right forStage IV Esophageal Squamous Cell Carcinoma Zhejiang University
Testing effectiveness (Phase 2)UnknownNCT05013697What this trial is testingTQB2450 Solution for Injection (TQB2450)+Paclitaxel+Cisplatin ± Anlotinib in the Treatment of Esophageal Cancer.Who this might be right forEsophageal Neoplasms Henan Cancer Hospital 48
Testing effectiveness (Phase 2)Looking for participantsNCT05969860What this trial is testingAt-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced CancerWho this might be right forAdvanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more Mayo Clinic 220
Not applicableStudy completedNCT02094105What this trial is testingEndoscopic Screening on Esophageal CancerWho this might be right forEsophageal Squamous Cell Carcinoma Chinese Academy of Medical Sciences 45,386
Early research (Phase 1)Looking for participantsNCT03740256What this trial is testingBinary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsWho this might be right forBladder CancerHead and Neck Squamous Cell CarcinomaCancer of the Salivary Gland+7 more Baylor College of Medicine 45
Testing effectiveness (Phase 2)Looking for participantsNCT07405151What this trial is testingA Clinical Trial of Ifinatamab Deruxtecan in People With Advanced Esophageal Cancer (MK-3475-06F)Who this might be right forOesophageal Squamous Cell Carcinoma Merck Sharp & Dohme LLC 60
Testing effectiveness (Phase 2)UnknownNCT05490719What this trial is testingA Phase II Study of CRT Combined With QL1706 in ESCC PatientsWho this might be right forEsophageal Squamous Cell Carcinoma Tianjin Medical University Cancer Institute and Hospital 39
Not applicableStudy completedNCT03244566What this trial is testingPET in Guiding Cervical Lymphadenectomy (ECTOP-2003)Who this might be right forEsophageal Cancer Fudan University 110
Testing effectiveness (Phase 2)Study completedNCT04732494What this trial is testingAnti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma BeiGene 125
Early research (Phase 1)Active Not RecruitingNCT05544929What this trial is testingSafety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersWho this might be right forCarcinoma, Non-Small-Cell LungCutaneous MelanomaCarcinoma, Renal Cell+9 more Novartis Pharmaceuticals 126
Early research (Phase 1)Looking for participantsNCT05208762What this trial is testingPF-08046054/SGN-PDL1V in Advanced Solid TumorsWho this might be right forCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and NeckEsophageal Squamous Cell Carcinoma+5 more Seagen, a wholly owned subsidiary of Pfizer 714
Not applicableLooking for participantsNCT06602843What this trial is testingNeoadjuvant Chemoimmunotherapy Followed by Surgery and Postoperative RadioimmunotherapyWho this might be right forEsophageal Squamous Cell Carcinoma Anhui Provincial Hospital 70
Not applicableUnknownNCT06103890What this trial is testingDynamic ctDNA Monitoring in Neoadjuvant Therapy for Esophageal Squamous Cell CarcinomaWho this might be right forEsophageal Squamous Cell Carcinoma Hebei Medical University Fourth Hospital 100
Early research (Phase 1)Study completedNCT03914443What this trial is testingA Feasibility Trial of Nivolumab With Neoadjuvant CF or DCF Therapy for Locally Advanced Esophageal CarcinomaWho this might be right forLocally Advanced Esophageal Squamous Cell Carcinoma National Cancer Center, Japan 37
Testing effectiveness (Phase 2)UnknownNCT00003326What this trial is testingPaclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the EsophagusWho this might be right forEsophageal Cancer Theradex 100
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06598917What this trial is testingMaintenance Chemotherapy With S-1, Locally Advanced Esophageal Cancer Receiving Definitive CCRTWho this might be right forLocally Advanced Unresectable Esophageal Cancer China Medical University Hospital 60
Testing effectiveness (Phase 2)WithdrawnNCT03307941What this trial is testingAssessment of Metabolic & Path Response w/ RCT & ImT Before Surgery in Locally Advanced Esoph and Gastro-esoph Jction CAWho this might be right forAdenocarcinoma of the EsophagusAdenocarcinoma of the Gastroesophageal JunctionSquamous Cell Carcinoma of the Esophagus Jules Bordet Institute
Not applicableUnknownNCT04425122What this trial is testingThe Microbiome of Oesophageal Squamous Cell CarcinomaWho this might be right forEsophageal CancerMicrobial Colonization Chinese University of Hong Kong 200